1. FRI0590 BIOMARKERS OF HEMODYNAMIC SEVERITY OF SYSTEMIC-SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION BY SERUM PROTEOME ANALYSIS. (2nd June 2020) Authors: Sanges, S.; Rice, L.; Tu, L.; Cracowski, J. L.; Montani, D.; Mantero, J.; Ternynck, C.; Marot, G.; Hachlla, E.; Launay, D.; Humbert, M.; Guignabert, C.; Lafyatis, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0093 Low runx3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis. (12th June 2018) Authors: Marut, W.; Affandi, A.; Broen, J.; Bossini-Castillo, L.; Ottria, A.; Tieland, R.; van Bon, L.; Rossato, M.; de Kroon, L.; van Roon, J.; Martin, J.; Lafyatis, R.; Radstake, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0241 Autotaxin is Over-Expressed in Systemic Sclerosis (SSC) Skin, Mediates Bleomycin-Induced Dermal Fibrosis via IL-6, and is A Target for SSC Therapy. (10th June 2014) Authors: Castelino, F.V.; George, L.M.; Bain, G.; Goulet, L.; Lafyatis, R.; Tager, A.M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0327 Cxcl4 drives fibrosis by promoting several key cellular and molecular processes. (12th June 2018) Authors: Marut, W.; Affandi, A.; Carvalheiro, T.; Ottria, A.; Haan, J.; Brandt, M.; Tieland, R.; Brans, M.; Malvar-Fernandez, B.; Bekker, C.; van der Linden, M.; Giovannone, B.; Heijnen, D.-J.; Kowalska, A.; Lafyatis, R.; Cheng, C.; de Jager, S.; van Roon, J.; Radstake, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma. (2019) Authors: Geskin, L.J.; Gaydosik, A.M.; Tabib, T.; Bayan, C.-A.; Conway, J.F.; Lafyatis, R.; Fuschiotti, P. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0060 Clinical Phenotypes of Systemic Sclerosis Impact Telomere and Telosome Function in Distinct Patterns. (23rd January 2014) Authors: Broen, J.; McGlynn, L.; Geurts-van Bon, L.; Lafyatis, R.; Radstake, T.; Shiels, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0329 SAFETY, TARGET ENGAGEMENT, AND INITIAL EFFICACY OF AVID200, A FIRST-IN-CLASS POTENT AND ISOFORM-SELECTIVE INHIBITOR OF TGF-BETA 1 AND 3, IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): A PHASE 1 DOSE ESCALATION STUDY. (2nd June 2020) Authors: Lafyatis, R.; Spiera, R.; Domsic, R.; Papazoglou, A.; Ligon, C.; Zinger Morse, C. M.; Denis, J. F.; Davis, M.; Gruosso, T.; Tremblay, G.; O'connor Mccourt, M.; Sinclair, S.; Delara, J.; Alvarado, K.; Wood, D.; Nadler, P.; Volkmann, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗